RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer
<i>RNF180</i> might be considered as a biological marker for aggressive behaviors and poor prognosis in EC and as a molecular target of gene therapy.
Authors
- Dao-fu Shen (ORCID: https://orcid.org/0000-0001-5331-6090)
- Zheng‐Guo Cui (ORCID: https://orcid.org/0000-0002-9756-9150)
- Ning Li (ORCID: https://orcid.org/0000-0002-3266-3322)
- Hua‐chuan Zheng
- Nanchang Yin
Institutions
- University of Fukui (JP)
- Chifeng Municipal Hospital (CN)
- Jinzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-22
- DOI
- https://doi.org/10.3389/fphar.2025.1525431
- Citations
- 1
- Primary Topic
- Lipid metabolism and biosynthesis
- Type
- article
- Field-Weighted Citation Impact
- 1.11